[e-drug] Praziquantel - clarification

[kitlerm@who.int]

E-drug: Praziquantel - clarification
---------------------------------------------

Following the message that I have sent out on the 10th of September 
entitled Praziquantel/help requested, and the first reactions to it 
that we have already received here in the World Health Organization, 
Iwould like to clarify the following:

	1.  There is no formal WHO initiative on Praziquantel.

	2.  Currently, WHO is collecting information (as per my previous
message) in order to identify any possible uncovered need to complement the
on-going excellent initiatives on Praziquantel, in view of the scaling up of
schistosomiasis  control activities in the endemic countries.

	3. For any information and queries on schistosomiasis control 
or the use of praziquantel please contact Dr Lorenzo Savioli 
(saviolil@who.int
<mailto:saviolil@who.int>) and/or Dr Dirk Engels (engelsd@who.int
<mailto:engelsd@who.int>)."

=======================================================

thank you for your assistance

Dr. Mary Ellen Kitler
The DEC Project
CPE/CEE/FIL   L315
World Health Organization
CH 1211 Geneva 27, Switzerland

Direct phone              41 22 791 3507
Departmental fax        41 22 791 4777
Direct e mail               kitlerm@who.int
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html